Table 2.

The most recent clinical trials with curcumin.

Cancer	Drug	Title	Clinical Trial Number (NCT)	Trial Phase	Estimated Study Completion Date
Breast	Curcumin	A “Window Trial” on Curcumin for Invasive Breast Cancer Primary Tumors	NCT03980509	I	November, 2021
	Curcumin® (CUC-01) with paclitaxel	Study of Efficacy of Curcumin in Combination With Chemotherapy in Patients With Advanced Breast Cancer	NCT03072992	II	July, 2018
Prostate	Curcumin	A Randomized, Double-Blind, Placebo-Controlled Trial of Curcumin to Prevent Progression of Biopsy Proven, Low-risk Localized Prostate Cancer Patients Undergoing Active Surveillance	NCT03769766	III	November, 2026
Cervical and Uterine	Immunomodulatory cocktail (Vitamin D, aspirin, Cyclophosphamide and Lansoprazole), pembrolizumab and Curcumin	A Phase II Investigation of Pembrolizumab (Keytruda) in Combination With Radiation and an Immune Modulatory Cocktail in Patients With Cervical and Uterine Cancer (PRIMMO Trial)	NCT03192059	II	June, 2022